We are live on
!
Find out more
ACM
Altrius Capital Management Portfolio holdings
AUM
$503M
1-Year Est. Return
19.46%
This Fund
S&P 500
This Quarter
Est. Return
-7.12%
1 Year Est. Return
+19.46%
3 Year Est. Return
+40.58%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$308M
AUM Growth
–
Cap. Flow
+$327M
Cap. Flow
% of AUM
106.24%
Top 10 Holdings %
Top 10 Hldgs %
17.66%
Holding
87
New
87
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$7.01M |
| 2 |
Chevron
CVX
|
+$6.19M |
| 3 |
AbbVie
ABBV
|
+$5.65M |
| 4 |
American International
AIG
|
+$5.54M |
| 5 |
Lockheed Martin
LMT
|
+$5.25M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.35% |
| 2 | Consumer Staples | 14.32% |
| 3 | Financials | 13.75% |
| 4 | Industrials | 10.67% |
| 5 | Consumer Discretionary | 9.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
ExxonMobil
XOM
$640B
| $6.66M | 2.16% |
+77,734
| New | +$7.01M |
|
|
2
AbbVie
ABBV
$448B
| $5.66M | 1.84% |
+36,975
| New | +$5.65M |
|
|
3
Chevron
CVX
$384B
| $5.42M | 1.76% |
+37,423
| New | +$6.19M |
|
4
Pfizer
PFE
$141B
| $5.33M | 1.73% |
+101,770
| New | +$5.19M |
|
5
AstraZeneca
AZN
$263B
| $5.27M | 1.71% |
+39,896
| New | +$5.23M |
|
6
Bristol-Myers Squibb
BMY
$124B
| $5.24M | 1.7% |
+68,039
| New | +$5.18M |
|
|
7
Lockheed Martin
LMT
$119B
| $5.14M | 1.67% |
+11,951
| New | +$5.25M |
|
8
Cigna
CI
$75.4B
| $5.04M | 1.64% |
+19,111
| New | +$4.92M |
|
9
General Dynamics
GD
$101B
| $5M | 1.62% |
+22,594
| New | +$5.2M |
|
10
Merck
MRK
$315B
| $4.97M | 1.61% |
+54,496
| New | +$4.83M |
|
|
11
American International
AIG
$41.5B
| $4.87M | 1.58% |
+95,331
| New | +$5.54M |
|
12
British American Tobacco
BTI
$134B
| $4.84M | 1.57% |
+112,793
| New | +$4.84M |
|
13
PepsiCo
PEP
$185B
| $4.82M | 1.57% |
+28,906
| New | +$4.87M |
|
14
Coca-Cola
KO
$354B
| $4.75M | 1.54% |
+75,505
| New | +$4.79M |
|
15
Tyson Foods
TSN
$20.1B
| $4.72M | 1.53% |
+54,813
| New | +$4.91M |
|
16
IBM
IBM
$193B
| $4.6M | 1.5% |
+32,615
| New | +$4.4M |
|
17
GSK
GSK
$102B
| $4.6M | 1.49% |
+84,473
| New | +$4.66M |
|
18
Johnson & Johnson
JNJ
$615B
| $4.57M | 1.49% |
+25,751
| New | +$4.59M |
|
19
Procter & Gamble
PG
$347B
| $4.56M | 1.48% |
+31,735
| New | +$4.77M |
|
|
BAY
20
DELISTED
BAYER AG SPONS ADR
BAY
| $4.5M | 1.46% |
+302,988
| New | +$4.5M |
|
21
Kraft Heinz
KHC
$30.8B
| $4.46M | 1.45% |
+117,036
| New | +$4.69M |
|
22
Philip Morris
PM
$303B
| $4.45M | 1.45% |
+45,068
| New | +$4.59M |
|
23
BP
BP
$112B
| $4.43M | 1.44% |
+156,349
| New | +$4.79M |
|
24
Amcor
AMCR
$20B
| $4.42M | 1.44% |
+71,112
| New | +$4.4M |
|
25
Packaging Corp of America
PKG
$20.3B
| $4.4M | 1.43% |
+31,986
| New | +$4.94M |
|
Similar funds
NB
AFGAS
HP
MWP
PRP
TCM
SWA
MCCP
Altrius Capital Management's Q2 2022 Portfolio in Review
Q2 2022 is the first quarter with a 13F filing on record for Altrius Capital Management, which disclosed 87 positions worth $308M. Its ten largest holdings account for 18% of the portfolio.
Its largest position is ExxonMobil: 77,734 shares worth $6.66M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, followed by Consumer Staples and Financials.
- Altrius Capital Management's largest Q2 2022 buy was ExxonMobil: 77,734 shares worth $6.66M.
- Altrius Capital Management's ten largest holdings make up 18% of its $308M portfolio in Q2 2022.
- Altrius Capital Management disclosed 87 positions in Q2 2022, its first 13F filing on record.
Based on Altrius Capital Management's 13F filing for Q2 2022, filed 9 Aug 2022.